The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
5,852
Sort by:
North America: Vitamins Market
US$ 1,999.00
... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...
June 2025
150 pages
Biologic Therapeutic Drugs: Technologies and Global Markets
US$ 4,650.00
Report This report provides an overview of the global biologic therapeutic drug market and analyzes market trends. It includes global revenue ($U.S. millions) for base year data for 2023 and estimated...
May 2025
170 pages
Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2030
US$ 4,950.00
The global market for oral proteins and peptides is projected to reach USD 24.00 billion by 2030 from USD 8.85 billion in 2025, at a CAGR of 22.1% during the forecast period from 2025 to 2030. The inc...
April 2025
326 pages
Activated Carbon, Other Activated Natural Mineral Products, Animal Black: European Union Market Outlook 2025 and Forecast till 2029
US$ 1,800.00
... analysis of the European Union market for activated carbon, other activated natural mineral products, animal black, covering EU ... consumers of activated carbon, other activated natural mineral products, animal black are briefly overviewed as well. Activated Carbon, Other Activated Natural Mineral Products, ...
February 2025
40 pages
Antibiotics: European Union Market Outlook 2025 and Forecast till 2029
US$ 1,800.00
Antibiotics: European Union Market Outlook 2018 and Forecast till 2023 provides a complete overview of the market condition. All available data is presented in ... an in-depth analysis of the European Union market for antibiotics, covering EU total and local markets. It provides current statistics, historical ...
February 2025
40 pages
Global Difluprednate Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
... are 15 Chapters to deeply display the global Difluprednate market. Chapter 1, to describe Difluprednate Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...
January 2025
104 pages
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2025-2033
US$ 2,999.00
The global generic drugs market size reached USD 389.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 674.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.66% dur...
January 2025
136 pages
Medical Cannabis Market Report by Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceutical Industry, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2025-2033
US$ 2,999.00
The global medical cannabis market size reached USD 37.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 68.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.1% dur...
January 2025
125 pages
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033
US$ 2,999.00
The global specialty generics market size reached USD 81.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 178.6 Billion by 2033, exhibiting a growth rate (CAGR) of 9.1%...
January 2025
127 pages
Global Tumor Necrosis Factor Inhibitor Drugs Market Size Study by Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), by Application (Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, Crohn’s Disease, and Others), by Sales Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), and Regional Forecasts 2022-2032
US$ 3,218.00
TNF inhibitors are pivotal in treating autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriasis, and Crohn’s disease, by targeting and inhibiting the action of tumor necrosis...
January 2025
285 pages
